In response to mounting concerns over shortages of critical chemotherapies and other drugs, the Federal Trade Commission (FTC) has announced a sweeping investigation into the role of companies facilitating the purchase and distribution of medicines to U.S. hospitals.
The probe, initiated by FTC Chair Lina Khan, aims to shed light on the operations of often-overlooked entities within the drug supply chain, whose actions can significantly impact the availability of essential medications.
The inquiry will delve into whether companies involved in brokering drug purchases for hospitals, as well as the intermediaries responsible for shipping these medicines, have exploited their market influence to drive down prices of generic drugs to such an extent that manufacturers are unable to sustain production, thereby exacerbating shortages.
Read more: Acting FTC Chief Wants New Approach For Analyzing Pharma Mergers
FTC Chair Lina Khan underscored the urgency of addressing these issues, stating, “For years Americans have faced acute shortages of critical drugs, from chemotherapy to antibiotics, endangering patients.” She emphasized the need to scrutinize the practices of opaque drug middlemen and identify the factors contributing to these shortages.
As part of the investigation, the FTC will request information from drug distributors and hospital purchasing groups, focusing on their contracting practices, market concentration, and compensation structures. This comprehensive approach aims to uncover any anticompetitive behavior or market distortions that may be driving the drug shortages plaguing the healthcare system.
Source: WSJ
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI